Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.

Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.

Item
http://www.wikidata.org/entity/Q35386228
Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: a review of scientific, program, and policy advances for sub-Saharan AfricaMaternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after deliveryEffectiveness of a prevention of mother-to-child HIV transmission programme in an urban hospital in AngolaMother to Mother (M2M) peer support for women in Prevention of Mother to Child Transmission (PMTCT) programmes: a qualitative study.Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.Initial programmatic implementation of WHO option B in Botswana associated with increased projected MTCTProgress in the prevention of mother to child transmission of HIV in three regions of Tanzania: a retrospective analysis.Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.Tracking the progress of HIV: the impact of point-of-care tests on antiretroviral therapyA post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.HIV in Africa: Challenges and Directions for the Next Decade.[Use of dried blood spots in early diagnosis of HIV-1 infection in children born to HIV-infected mothers as part of the prevention of mother-to-child transmission in Benin].
P2860

Highly active antiretroviral therapy versus zidovudine for prevention of mother-to-child transmission in a programmatic setting, Botswana.

Item
http://www.wikidata.org/entity/Q35386228
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@ast
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
type
label
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@ast
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
prefLabel
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@ast
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Highly active antiretroviral t ...... rogrammatic setting, Botswana.
@en
P2093
P2860
P304
P31
P356
10.1097/QAI.0B013E31822D4063
P407
P433
P478
P50
P577
P698
P921
P932